Benzinga | May 20, 2021 08:01AM EDT

Soleno Therapeutics To Participate In Oppenheimer Rare & Orphan Disease Summit May 21 At 1:15 p.m. ET

Soleno Therapeutics, Inc. ("Soleno") (NASDAQ:SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that Anish Bhatnagar, M.D., Chief Executive Officer, will present a corporate overview at the Oppenheimer Rare & Orphan Disease Summit on Friday, May 21, 2021 at 1:15 PM Eastern Time.



A live audio webcast and replay of the presentation will be available in the Investors section on the Company's website at www.soleno.life.